Doxycycline
NDC Package 76519-1134-4

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Doxycycline is a medication contraindicated in persons who have shown hypersensitivity to any of the tetracyclines. Marketed by H.j. Harkins Co., Inc., this product is identified by NDC 76519-1134 and is authorized under FDA application ANDA204446.

Identification & Billing

NDC Package Code
76519-1134-4
Package Description
14 CAPSULE in 1 VIAL
Product Code
76519-1134
11-Digit Billing Format
76519113404
RxNorm Crosswalk
RxCUI: 1649990 - doxycycline monohydrate 100 MG Oral Capsule

Clinical Specifications

Proprietary Name
Doxycycline
Dosage Form
-
Usage Information
This drug is contraindicated in persons who have shown hypersensitivity to any of the tetracyclines.

Regulatory & Marketing

Labeler Name
H.j. Harkins Co., Inc.
FDA Application #
ANDA204446
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
12-04-2017
Listing Expiration
12-31-2019
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 76519-1134-4 identifies a specific commercial package of 14 capsule in 1 vial of Doxycycline, labeled by H.j. Harkins Co., Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by H.j. Harkins Co., Inc. on December 04, 2017. The current certification is valid through December 31, 2019.

How is this H.j. Harkins Co., Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 76519113404. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
76519-1134-4
11-Digit CMS (5-4-2)
76519-1134-04

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.